Stalevo 50 Interactions
There are 503 drugs known to interact with Stalevo 50 (carbidopa/entacapone/levodopa), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 46 are major, 445 are moderate, and 12 are minor.
- View all 503 medications that may interact with Stalevo 50
- View Stalevo 50 alcohol/food interactions (2)
- View Stalevo 50 disease interactions (13)
Most frequently checked interactions
View interaction reports for Stalevo 50 (carbidopa / entacapone / levodopa) and the medicines listed below.
- acetaminophen
- amantadine
- Ambien CR (zolpidem)
- Apokyn (apomorphine)
- aspirin
- atenolol
- Azilect (rasagiline)
- baclofen
- Celebrex (celecoxib)
- Claritin (loratadine)
- clonazepam
- Colace (docusate)
- diclofenac
- fexofenadine
- fludrocortisone
- fluticasone nasal
- gabapentin
- ibuprofen
- Klonopin (clonazepam)
- Lipitor (atorvastatin)
- lisinopril
- lorazepam
- midodrine
- Mirapex (pramipexole)
- Neupro (rotigotine)
- Requip (ropinirole)
- selegiline
- Sinemet (carbidopa / levodopa)
- Sinemet CR (carbidopa / levodopa)
- Vitamin D3 (cholecalciferol)
Stalevo 50 alcohol/food interactions
There are 2 alcohol/food interactions with Stalevo 50 (carbidopa / entacapone / levodopa).
Stalevo 50 disease interactions
There are 13 disease interactions with Stalevo 50 (carbidopa / entacapone / levodopa) which include:
- glaucoma
- cardiac disease
- hypotension
- neuroleptic malignant syndrome
- psychoses/depression
- psychosis
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- hepatic impairment
- GI bleeding
More about Stalevo 50 (carbidopa / entacapone / levodopa)
- Stalevo 50 consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: dopaminergic antiparkinsonism agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.